newsfilter
← Latest News
GlobeNewswire·

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

REDWOOD CITY, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today